Influence of hydroxypropyl methylcellulose on drug release pattern of a gastroretentive floating drug delivery system using a 32 full factorial design

Pharmaceutical Development and Technology

Volumn 14, Issue 2, 2009, Pages 193-198

  Swain, Kalpana ^a   Pattnaik, Satyanarayan ^a   Mallick, Subrata ^b   Chowdary, Korla Appana ^c  

^a Department of Pharmaceutics   (India)

^b SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

^c ROLAND INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Controlled release; Factorial design; Gastroretentive system; HPMC; Theophylline

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; POLYMER; THEOPHYLLINE; BRONCHODILATING AGENT; DRUG CARRIER; DRUG DERIVATIVE; METHYLCELLULOSE;

ARTICLE; BIOCOMPATIBILITY; CONTROLLED DRUG RELEASE; DEPENDENT VARIABLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TRANSPORT; FACTORIAL DESIGN; PRIORITY JOURNAL; RESPONSE SURFACE METHOD; RESPONSE VARIABLE; STOMACH JUICE; VISCOSITY; CHEMISTRY; DIFFUSION; MULTIVARIATE ANALYSIS; TABLET; TIME;

BRONCHODILATOR AGENTS; DIFFUSION; DRUG CARRIERS; METHYLCELLULOSE; MULTIVARIATE ANALYSIS; TABLETS; THEOPHYLLINE; TIME FACTORS; VISCOSITY;

EID: 69249208846     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450802498902     Document Type: Article

References (23)

1. Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm. (1996);136, 117-139.
2. Sood A, Panchagnula R. Design of controlled release delivery systems using a modified pharmacokinetic approach: a case study for drugs having a short elimination half-life and a narrow therapeutic index. Int. J. Pharm. (2003);261, 27-41.
3. Brijesh SD, Avani FA, Madhabhai MP. Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS. PharmSciTech. (2004);5, Article 34.
4. Ponchel G, Irache JM. Specific and non-specific bioadhesive particulate system for oral delivery to the gastrointestinal tract. Adv. Drug Del. Rev. (1998);34, 191-219.
5. Deshpande AA, Shah NH, Rhodes CT, Malick W. Development of a novel controlled-release system for gastric retention. Pharm. Res. (1997);14, 815-819.
6. Chueh HR, Zia H, Rhodes CT. Optimization of sotalol floating and bioadhesive extended release tablet formulations. Drug Dev. Ind. Pharm. (1995);21, 1725-1747.
7. Davis SS, Stockwell AF, Taylor MJ et al. The effect of density on the gastric emptying of single and multiple unit dosage forms. Pharm. Res. (1986);3, 208-213.
8. Urguhart J, Theeuwes F, inventors.Drug delivery system comprising a reservoir containing a plurality of tiny pills. US patent (1994);4 434 153.
9. Fix JA, Cargill R, Engle K. Controlled gastric emptying III. Gastric residence time of a non-disintegrating geometric shape in human volunteers. Pharm. Res. (1993);10, 1087-1089.
10. Groning R, Heun G. Oral dosage forms with controlled gastrointestinal transit. Drug Dev. Ind. Pharm. (1984);10, 527-539.
11. Ichikawa M, Watanabe S, Miyake Y, inventors. Granule remaining in stomach. US patent (1989);4 844 905.
12. Yang L, Esharghi J, Fassihi R. A new intra gastric delivery system for the treatment of helicobacter pylori associated gastric ulcers: in vitro evaluation. J. Control. Release. (1999);57, 215-222.
13. Li S, Lin S, Daggy BP, Mirchandani HL, Chien TW. Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev. Ind. Pharm. (2002);28, 783-793.
14. Atyabi F, Sharma HL, Mohammad HA, Fell JT. In vivo evaluation of a novel gastric retentive formulation based on ion exchange resins. J. Control Release. (1996);42, 105-113.
15. Hendeles L, Weinberger M, Johnson G. Monitoring serum theophylline levels. Clin. Pharmacokinet. (1978);3, 294-312.
16. Vazquez MJ, Perez-Marcos B, Gomez-Amoza JL, Matinez- Pacheco R, Souto C, Concheiro A. Influence of technological variables on drug release of drug from hydrophilic matrices. Drug Dev. Ind. Pharm. (1992);18, 1355-1375.
17. Ford JL, Rubinstein MH, Hogan JE. Formulation of sustained release promethazine hydrochloride tablet using HPMC matrices. Int. J. Pharm. (1985);24, 327-337.
18. Rosa JCM, Zia H, Christopher TR. Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int. J. Pharm. (1994);105, 65-70.
19. Chu JS, Amidon GL, Weiner ND, Goldberg AH. Mixture experimental design in the development of a mucoadhesive gel formulation. Pharm. Res. (1991);8, 1401-1407.
20. Garcia Gonzalez N, Kellaway IW, Blanco-Fuente H, Anguiano- Igea S, Blanco-Mendez J. Design and evaluation of buccoadhesive metoclopramide hydrogels composed of poly (acrylic acid) crosslinked with sucrose. Int. J. Pharm. (1993);100, 65-70.
21. Campos-Aldrete ME, Villafuerte-Robles L. Influence of the viscosity grade and particle size of HPMC on metronidazole release from matrix tablets. Eur. J. Pharm. Biopharm. (1997);43, 173-178.
22. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. (1985);60, 110-111.
23. Ritger PL, Peppas NA. A simple equation for description of solute release. II Fickian and anomalous release from swellable devices. J. Control. Release. (1987);5, 37-42.